MicroGenDX
Biotechnology Research • 
Orlando, Florida, United States • 51-100 Employees
Company overview
| Headquarters | 5786 Hoffner Ave, Orlando , Florida 32822, US |
| Phone number | +18552080019 |
| Website | |
| NAICS | 541714 |
| SIC | 807 |
| Keywords | Urology, Orthopedics, Diagnostics, Microbiology, Wound Care, Podiatry, ENT, Gastrointestinal, Next Generation Sequencing, Qpcr, NGS, Respiratory, Infectious Disease, Molecular, Labaratory, Obgyn/ Vaginal, Urogenital |
| Founded | 2008 |
| Employees | 51-100 |
| Socials |
Key Contact at MicroGenDX
MicroGenDX Email Formats
MicroGenDX uses 4 email formats. The most common is {first name}.{last name} (e.g., john.doe@microgendx.com), used 84.5% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}.{last name} | john.doe@microgendx.com | 84.5% |
{first initial}.{last name} | j.doe@microgendx.com | 12.1% |
{last name} | doe@microgendx.com | 1.7% |
{last name}.{last name} | doe.doe@microgendx.com | 1.7% |
About MicroGenDX
MicroGenDX provides qPCR+NGS sequencing for the detection of infectious diseases. The American Medical Association (AMA) and Medicare have issued a billing code to MicroGenDX to provide this testing service, recognizing this technology as medically necessary. MicroGenDX is trusted by over 39,000 physicians worldwide and has helped over 900,000 patients with diagnostic testing for their chronic and life-threatening infections. MicroGenDX is a College of American Pathologists (CAP) accredited and Clinical Laboratory Improvements Amendments (CLIA) licensed clinical laboratory. Tens of thousands of patients with chronic and often life-threatening infections have benefited from MicroGenDX’s work. MicroGenDX's NGS technology offers several advantages over traditional culture-based methods for identifying microorganisms. It can detect a wider range of microorganisms, including those that are difficult to culture or grow in a laboratory. It also provides more accurate and comprehensive results, as it can detect multiple microorganisms in a single sample and identify them at the species or strain level. Additionally, NGS technology is faster than traditional methods, allowing for quicker diagnosis and treatment decisions. MicroGenDX's testing services are used in a variety of settings, including hospitals, long-term care facilities, dental offices, and veterinary clinics. Their technology has been applied to a wide range of clinical conditions, including chronic wounds, orthopedic infections, respiratory infections, and urinary tract infections, among others.
MicroGenDX revenue & valuation
| Annual revenue | $20,000,000 |
| Revenue per employee | $205,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $64,000,000 |
| Total funding | No funding |
Employees by Management Level
Total employees: 51-100
Seniority
Employees
Employees by Department
MicroGenDX has 52 employees across 11 departments.
Departments
Number of employees
Funding Data
MicroGenDX has never raised funding before.
MicroGenDX Tech Stack
Discover the technologies and tools that power MicroGenDX's digital infrastructure, from frameworks to analytics platforms.
Video players
Security
Form builders
JavaScript libraries
JavaScript libraries
Analytics
JavaScript libraries
CDN
Font scripts
JavaScript libraries
Programming languages
Blogs
United Kingdom
Sri Lanka
France
Denmark
Italy
Austria
Frequently asked questions
4.8
40,000 users
